4.5 Article

Receptor mediated uptake of paclitaxel from a synthetic high density lipoprotein nanocarrier

Related references

Note: Only part of the references are listed.
Review Pharmacology & Pharmacy

Ligand-based targeted therapy for cancer tissue

Manasi Das et al.

EXPERT OPINION ON DRUG DELIVERY (2009)

Article Oncology

Design of Folate-Linked Liposomal Doxorubicin to its Antitumor Effect in Mice

Atsushi Yamada et al.

CLINICAL CANCER RESEARCH (2008)

Article Pathology

Targeted therapy of cancer: new roles for pathologists in colorectal cancer

Stanley R. Hamilton

MODERN PATHOLOGY (2008)

Article Pathology

Liposomal Nanomedicines: An Emerging Field

David B. Fenske et al.

TOXICOLOGIC PATHOLOGY (2008)

Article Chemistry, Multidisciplinary

Synthetic nano-LDL with paclitaxel oleate as a targeted drug delivery vehicle for glioblastoma multiforme

Mina Nikanjarn et al.

JOURNAL OF CONTROLLED RELEASE (2007)

Review Pharmacology & Pharmacy

Prospects and challenges of the development of lipoprotein-based formulations for anti-cancer drugs

Andras G. Lacko et al.

EXPERT OPINION ON DRUG DELIVERY (2007)

Article Pharmacology & Pharmacy

Synthetic nano-low density lipoprotein as targeted drug delivery vehicle for glioblastoma multiforme

Mina Nikanjam et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2007)

Article Multidisciplinary Sciences

Rerouting lipoprotein nanoparticles to selected alternate receptors for the targeted delivery of cancer diagnostic and therapeutic agents

G Zheng et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Article Medicine, Research & Experimental

Serum lipoprotein profile in patients with cancer. A comparison with non-cancer subjects

AM Fiorenza et al.

INTERNATIONAL JOURNAL OF CLINICAL & LABORATORY RESEARCH (2000)